GMAB
Genmab A/S
There isn't enough reported data to score GMAB yet.
UNH
UnitedHealth Group Incorporated
UNH's fundamentals are mixed: free cash flow grew 31%, but earnings per share fell 8.5%. At 23x earnings, it's trading right at its usual valuation. Analysts expect strong earnings growth, though they disagree widely on how much.
GMAB Fundamentals
| Metric | Status |
|---|---|
| Unavailable | |
| Strong | |
| Unavailable | |
| Strong |
GMAB's profitability and balance sheet are currently strong. There isn't enough data to rate its revenue and cash flow.
UNH Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Stable | |
| Healthy | |
| Healthy |
UNH's cash flow and balance sheet are currently healthy, and its revenue and profitability are stable.
GMAB PE Valuation
GMAB has no meaningful PE right now: it lost money over the past year.
UNH PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 18x | $405 | — |
| Cheap | 19x | $325 | -20% |
| Fair | 23x | $410 | +1.2% |
| Current | 23x | $405 | — |
| Expensive | 30x | $526 | +30% |
Historical ranges are pointers, not guarantees.
UNH's PE is in its fair range at 23x. If earnings grow as analysts expect, today's price would be 18x next year's earnings, in its cheap range.
GMAB Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Growth | |
| Growth | |
| Weakening | |
| Limited | |
| Low |
Analysts expect earnings and revenue growth for GMAB, but weaker profitability. However, they disagree widely on these estimates.
UNH Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Stable | |
| Improving | |
| Moderate | |
| Low |
Analysts expect UNH's earnings to grow and its profitability to improve, with its revenue holding steady. However, they disagree widely on these estimates.
GMAB Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q4 2024 | $12.16 | +85% |
| Q2 2024 | $6.59 | -12% |
| Q1 2024 | $6.85 | -9.9% |
| Q4 2023 | $6.59 | -14% |
| Q2 2023 | $7.48 | +81% |
| Q1 2023 | $7.60 | +101% |
| Q4 2022 | $7.66 | +95% |
| Q2 2022 | $4.14 | +48% |
GMAB has the stronger earnings trend. Trailing diluted EPS is up 63% for GMAB versus UNH down 8.5%.
UNH Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $22.65 | +29% |
| Q3 2026 | $17.55 | -8.5% |
| Q2 2026 | $15.58 | -33% |
| Q1 2026 | $13.28 | -44% |
| Q4 2025 | $13.23 | -15% |
| Q3 2025 | $19.17 | +25% |
| Q2 2025 | $23.09 | +53% |
| Q1 2025 | $23.89 | +46% |
| Q4 2024 | $15.51 | -35% |
UNH's earnings per share have fallen from their peak: $17.55 over the past year, against $23.89 in early 2025.
GMAB Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q4 2025 | $2.1B | +17% |
| Q4 2024 | $1.8B | +27% |
| Q2 2024 | $115.8M | -81% |
| Q1 2024 | $89.6M | -79% |
| Q4 2023 | $1.4B | +1.2% |
| Q2 2023 | $619.6M | +32% |
| Q1 2023 | $421.2M | +34% |
| Q4 2022 | $1.4B | +89% |
GMAB has the stronger quarterly revenue trend. Revenue is up 49% for GMAB versus down 0.4% for UNH.
| Quarter | Margin | YoY |
|---|---|---|
| Q4 2025 | 25% | -11 points |
| Q4 2024 | 36% | +0.4 points |
| Q2 2024 | 30% | +16 points |
| Q1 2024 | 19% | -30 points |
| Q4 2023 | 36% | -3.5 points |
| Q2 2023 | 35% | +11 points |
| Q1 2023 | 15% | -20 points |
| Q4 2022 | 49% | +9.4 points |
GMAB's operating margin was 25% last quarter, down 11 points from the same quarter a year ago.
UNH Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $112.7B | -0.4% |
| Q2 2026 | $112B | +0.4% |
| Q1 2026 | $111.7B | +2% |
| Q4 2025 | $113.2B | +12% |
| Q3 2025 | $113.2B | +12% |
| Q2 2025 | $111.6B | +13% |
| Q1 2025 | $109.6B | +9.8% |
| Q4 2024 | $100.8B | +6.8% |
UNH's revenue has held roughly level: $113B last quarter, about level with the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 5.8% | +2 points |
| Q2 2026 | 7.1% | +2.5 points |
| Q1 2026 | 8.1% | -0.3 points |
| Q4 2025 | 0.3% | -7.4 points |
| Q3 2025 | 3.8% | -4.8 points |
| Q2 2025 | 4.6% | -3.4 points |
| Q1 2025 | 8.3% | +0.4 points |
| Q4 2024 | 7.7% | -0.4 points |
UNH's operating margin was 5.8% last quarter, up 2 points from the same quarter a year ago.
GMAB Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q4 2025 | $822M | +20% |
| Q4 2024 | $685.5M | +30% |
| Q2 2024 | $32M | -37% |
| Q1 2024 | $32M | -93% |
| Q4 2023 | $526.7M | +63% |
| Q2 2023 | $50.4M | -62% |
| Q1 2023 | $465.3M | +491% |
| Q4 2022 | $323.1M | +300% |
GMAB has the stronger cash trend. Its trailing FCF is up 218% versus its history, compared with UNH at up 5.2%.
UNH Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $4.3B | -16% |
| Q2 2026 | $10.3B | +63% |
| Q1 2026 | $8.1B | +79% |
| Q4 2025 | $160M | -89% |
| Q3 2025 | $5.1B | -61% |
| Q2 2025 | $6.3B | +6.9% |
| Q1 2025 | $4.6B | +1037% |
| Q4 2024 | $1.5B | +$7.6B |
UNH still generates free cash flow, though less than at its 2022 peak: $22.8B over the past year.
GMAB Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -1.2% | -7.7M shares |
| 1 year | -1.7% | -10.9M shares |
| 3 years | +4.5% | +27.9M shares |
| 5 years | +4.8% | +30M shares |
GMAB has the edge over UNH on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q4 2025 | — |
| Q4 2024 | — |
| Q2 2024 | $65.1M |
| Q1 2024 | $11.7M |
| Q4 2023 | — |
| Q2 2023 | $5.2M |
| Q1 2023 | $92.4M |
| Q4 2022 | $94.8M |
UNH Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.4% | -4M shares |
| 1 year | -0.7% | -6M shares |
| 3 years | -3.6% | -34M shares |
| 5 years | -5.5% | -53M shares |
| Available history | -6.6% | -64M shares |
UNH has 902M diluted shares, down 0.7% from a year ago, with $5B in buybacks over the past year.
| Quarter | Spent |
|---|---|
| Q3 2026 | $3.4B |
| Q2 2026 | $1.6B |
| Q1 2026 | — |
| Q4 2025 | — |
| Q3 2025 | — |
| Q2 2025 | $2.5B |
| Q1 2025 | $3B |
| Q4 2024 | $5B |
UNH spent $5B buying back its own shares over the past year, down 52% from the year before.
GMAB Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q2 2019 | -0.4x | Net Cash |
| Q1 2019 | -0.9x | Net Cash |
| Q4 2018 | -0.4x | Net Cash |
| Q3 2018 | -0.6x | Net Cash |
| Q2 2018 | -0.9x | Net Cash |
| Q1 2018 | -0.6x | Net Cash |
| Q4 2017 | -1.0x | Net Cash |
| Q3 2017 | -0.8x | Net Cash |
GMAB has more cash than debt.
UNH Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 1.7x | Healthy |
| Q2 2026 | 1.7x | Healthy |
| Q1 2026 | 2.2x | Moderate |
| Q4 2025 | 2.3x | Moderate |
| Q3 2025 | 1.7x | Healthy |
| Q2 2025 | 1.5x | Healthy |
| Q1 2025 | 1.3x | Healthy |
| Q4 2024 | 1.4x | Healthy |
UNH's net debt is about 1.7 years of its operating earnings (EBITDA), about the same as a year ago.
GMAB Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 75.6 | Overbought |
| Stochastic | 81.0 | Overbought |
GMAB's weekly RSI is 76 (overbought) and its Stochastic is 81 (overbought).
UNH Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 56.4 | Neutral |
| Stochastic | 60.0 | Neutral |
UNH's weekly RSI is 56 (neutral) and its Stochastic is 60 (neutral).
GMAB PE vs Healthcare Sector
| Metric | GMAB | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 26x | — |
GMAB has no meaningful PE right now: it lost money over the past year.
UNH PE vs Healthcare Sector
| Metric | UNH | Sector median | Relative |
|---|---|---|---|
| PE | 23x | 26x | 11% below |
| PE % | 47 | 29 | 18 pts above |
UNH is trading at 23x earnings, a 11% discount to the Healthcare sector's median of 26x.
GMAB Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $43.8 | 18% above |
| 20 week MA | $36.3 | 43% above |
| 50 week MA | $31.8 | 63% above |
| 100 week MA | $27.7 | 87% above |
| 200 week MA | $29.7 | 74% above |
GMAB has the edge over UNH on trend strength, trading above more of its moving averages.
UNH Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $394.2 | 2.8% above |
| 20 week MA | $400.5 | 1.2% above |
| 50 week MA | $361.2 | 12% above |
| 100 week MA | $376.0 | 7.8% above |
| 200 week MA | $446.6 | 9.3% below |
UNH has bounced recently, but its long-term trend is still down: it's above its 8-, 20-, 50- and 100-week averages, but 9.3% below its 200-week average.
GMAB Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $22.3 | $39.1 | +76% |
| 2021 | $39.1 | $39.7 | +1.5% |
| 2022 | $39.7 | $43.1 | +8.5% |
| 2023 | $43.1 | $31.8 | -26% |
| 2024 | $31.8 | $21.0 | -34% |
| 2025 | $21.0 | $33.4 | +59% |
| 2026 YTD | $33.4 | $51.7 | +55% |
GMAB has the edge over UNH on returns for 2026, with the stronger performance.
UNH Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $296.0 | $340.8 | +15% |
| 2021 | $340.8 | $495.4 | +45% |
| 2022 | $495.4 | $531.3 | +7.3% |
| 2023 | $531.3 | $526.5 | -0.9% |
| 2024 | $526.5 | $510.0 | -3.1% |
| 2025 | $510.0 | $331.8 | -35% |
| 2026 YTD | $331.8 | $405.1 | +22% |
UNH has finished three years in a row lower, and it's up 22% so far in 2026.